Blue Faery will host HCC Lunch & Learn—Dallas, a free educational event on September 27, 2025, from 10 a.m. to 3 p.m. at Concord Church. The event offers Dallas residents aged 16 and over the opportunity to learn about liver health, disease prevention, and hepatocellular carcinoma (HCC) treatment while enjoying a catered lunch.
UT Southwestern physicians will provide critical insights on how liver disease and HCC develop, the role of multidisciplinary care teams, available community resources, and therapeutic options for both transplant-eligible and non-eligible patients. Attendees will also hear first-hand personal stories from individuals affected by HCC, adding a human dimension to the medical information presented.
The event represents an important community health initiative that could significantly impact liver cancer awareness and early detection in the Dallas area. With liver cancer being one of the leading causes of cancer deaths worldwide, such educational gatherings provide vital information that could lead to earlier interventions and better treatment outcomes for at-risk individuals.
Space for the event is limited, and registration is required through the HCC Lunch & Learn registration page. Blue Faery's comprehensive educational approach includes their online Liver Cancer Community for patients and caregivers, as well as free Patient Resource Guides for Liver Cancer available on their website.
The 2025 HCC Lunch & Learn is sponsored by pharmaceutical companies AstraZeneca, Exelixis, and Merck, highlighting the collaborative effort between non-profit organizations and industry partners in addressing liver cancer education. Blue Faery's mission focuses on preventing, treating, and curing primary liver cancer through research, education, and advocacy, with additional programs including Love Your Liver, The Truth About Liver Cancer, and You and Liver Cancer.
This event demonstrates the growing importance of community-based health education in combating serious diseases like liver cancer. By providing free access to expert medical knowledge and personal experiences, such initiatives empower individuals to make informed healthcare decisions and potentially improve early detection rates for this often-silent disease.
